Hemodynamic effects of iodixanol and iohexol during ventriculography in patients with compromised left ventricular function

✍ Scribed by Arend Bergstra; René B. van Dijk; Oddmund Brekke; Arie E. Buurma; Leandro Orozco; Peter den Heijer; Harry J.G.M. Crijns

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 155 KB
• Volume: 50
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/1522-726x(200007)50:3<314::aid-ccd9>3.0.co;2-d

✦ Synopsis

A crossover study was performed to compare the hemodynamic effects of the isoosmolar contrast agent iodixanol (Visipaqueா) 320 mg I/ml to those of the low-osmolar iohexol (Omnipaqueா) 350 mg I/ml. The main hypothesis was that iodixanol and iohexol would affect left ventricular end-diastolic pressure (LVEDP) to different degrees. In 48 patients with reduced cardiac function (mean ejection fraction 33.4%), one ventricular injection was performed with each contrast medium. Ventricular, aortic and right atrial pressures and heart rate were measured continuously. Cardiac output (using Fick's principle) and systemic vascular resistance were calculated. LVEDP increased with both agents, but significantly less after iodixanol than after iohexol (P < 0.01), also in subgroups of patients in whom baseline LVEDP was severely increased and in whom 3-vessel disease was present. Immediate changes in variables reflecting vasodilatation were similar with both agents. In conclusion, both contrast agents influenced hemodynamics during ventriculography, but iodixanol had significantly less influence on LVEDP than did iohexol.